GSK’s Arexvy Vaccine For RSV Approved In Malaysia

KUALA LUMPUR, GlaxoSmithKline Pharmaceutical Sdn Bhd (GSK) today announced that the Arexvy vaccine (MAL24086007ARZ) has been approved in Malaysia for respiratory syncytial virus (RSV).

RSV is a common respiratory virus that can lead to serious negat…

Read More »